Fundraising Fox
Grapheal
Founded 2019 · 9 employees on LinkedIn · 3 known investors
Find your way into Grapheal
Sign up to find every way you can get introduced to Grapheal
- Your email: who you already know at Grapheal, and who your contacts know
- 2nd- and 3rd-degree connections: people you know who worked, studied or invested with the Grapheal team
- Your LinkedIn: the connections who can make the intro for you
We rank every route by how warm it is, so you raise on warm intros instead of cold emails.
Grapheal develops graphene-based biosensors, including PFAST, a field-deployable device for fast, real-time detection of ultra-trace PFAS ("forever chemicals") in water. The platform enables point-of-need testing to support PFAS monitoring under regulations such as the EU Drinking Water Directive.
Investors · 3
How we know: Novalis Biotech's portfolio page · graphene-info.com · funding news · Not right? Tell us
How we know: graphene-info.com · funding news · Not right? Tell us
How we know: finsmes.com · Not right? Tell us
Funding
SEC filings, press & company announcementsSource: company announcements and press reports — follow each round's link for the claim.
In the news
Frequently asked questions
- What does Grapheal do?
- Grapheal develops graphene-based biosensors, including PFAST, a field-deployable device for fast, real-time detection of ultra-trace PFAS ("forever chemicals") in water. The platform enables point-of-need testing to support PFAS monitoring under regulations such as the EU Drinking Water Directive.
- Who are Grapheal's investors?
- Grapheal's investors include Novalis Biotech, Bpifrance, EIC.